前沿论文｜CELL INTELLIGENCE

Claudin-18.2: Molecular mechanisms to clinical translation in solid tumors (Review).

PubMed 2026/08/12 发表Oncol LettQ3 · IF 2.1（JCR 2025）

Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity.

PubMed 2026/05/04 发表Mol Cancer TherQ1 · IF 6.9（JCR 2025）

Development of tri-cistronic CLDN18.2 CAR-T cells incorporating PD-1/CD28 switch and cyclophilin A for enhanced solid tumor immunotherapy.

PubMed 2026/01/31 发表J MicrobiolQ2 · IF 3.8（JCR 2025）

Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer.

PubMed 2024/03/06 发表Front OncolQ2 · IF 3.4（JCR 2025）

前沿论文 4